| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-05 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.003 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.092 | 0.006 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.092 | 0.006 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.007 |